These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 35623698)

  • 1. Emerging mechanisms of targeted protein degradation by molecular glues.
    Frere GA; de Araujo ED; Gunning PT
    Methods Cell Biol; 2022; 169():1-26. PubMed ID: 35623698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Translation of Targeted Protein Degraders.
    Kong NR; Jones LH
    Clin Pharmacol Ther; 2023 Sep; 114(3):558-568. PubMed ID: 37399310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted protein degradation: Emerging concepts and protein state-specific targeting principles.
    Tao AJ; Gadbois GE; Buczynski SA; Ferguson FM
    Curr Opin Chem Biol; 2022 Apr; 67():102114. PubMed ID: 35042023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haven't got a glue: Protein surface variation for the design of molecular glue degraders.
    Kozicka Z; Thomä NH
    Cell Chem Biol; 2021 Jul; 28(7):1032-1047. PubMed ID: 33930325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-Molecule Degraders beyond PROTACs-Challenges and Opportunities.
    Kastl JM; Davies G; Godsman E; Holdgate GA
    SLAS Discov; 2021 Apr; 26(4):524-533. PubMed ID: 33632029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligandability of E3 Ligases for Targeted Protein Degradation Applications.
    Belcher BP; Ward CC; Nomura DK
    Biochemistry; 2023 Feb; 62(3):588-600. PubMed ID: 34473924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced protein degradation for therapeutics: past, present, and future.
    Yoon H; Rutter JC; Li YD; Ebert BL
    J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 38165043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation.
    Oleinikovas V; Gainza P; Ryckmans T; Fasching B; Thomä NH
    Annu Rev Pharmacol Toxicol; 2024 Jan; 64():291-312. PubMed ID: 37585660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical and Computational Approaches to Study Ternary Complexes: A 'Cooperative Relationship' to Rationalize Targeted Protein Degradation.
    Ward JA; Perez-Lopez C; Mayor-Ruiz C
    Chembiochem; 2023 May; 24(10):e202300163. PubMed ID: 37018140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of biophysical methods for monitoring protein proximity induction in the development of small molecule degraders.
    Przytulski K; Glaza P; Brach K; Sagan M; Statkiewicz G; Klajn J; Walczak MJ
    Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130398. PubMed ID: 37301332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chasing molecular glue degraders: screening approaches.
    Domostegui A; Nieto-Barrado L; Perez-Lopez C; Mayor-Ruiz C
    Chem Soc Rev; 2022 Jul; 51(13):5498-5517. PubMed ID: 35723413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic.
    Sasso JM; Tenchov R; Wang D; Johnson LS; Wang X; Zhou QA
    Biochemistry; 2023 Feb; 62(3):601-623. PubMed ID: 35856839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging strategies for prospective discovery of molecular glue degraders.
    Wang B; Cao S; Zheng N
    Curr Opin Struct Biol; 2024 Jun; 86():102811. PubMed ID: 38598983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key Considerations in Targeted Protein Degradation Drug Discovery and Development.
    Qin L; Dai H; Wang J
    Front Chem; 2022; 10():934337. PubMed ID: 35978859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing targeted protein degrader discovery by measuring cereblon engagement in cells.
    Zerfas BL; Huerta F; Liu H; Du G; Gray NS; Jones LH; Nowak RP
    Methods Enzymol; 2023; 681():169-188. PubMed ID: 36764756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Driving E3 Ligase Substrate Specificity for Targeted Protein Degradation: Lessons from Nature and the Laboratory.
    Cowan AD; Ciulli A
    Annu Rev Biochem; 2022 Jun; 91():295-319. PubMed ID: 35320687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E3-Specific Degrader Discovery by Dynamic Tracing of Substrate Receptor Abundance.
    Hanzl A; Barone E; Bauer S; Yue H; Nowak RP; Hahn E; Pankevich EV; Koren A; Kubicek S; Fischer ES; Winter GE
    J Am Chem Soc; 2023 Jan; 145(2):1176-1184. PubMed ID: 36602777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design principles for cyclin K molecular glue degraders.
    Kozicka Z; Suchyta DJ; Focht V; Kempf G; Petzold G; Jentzsch M; Zou C; Di Genua C; Donovan KA; Coomar S; Cigler M; Mayor-Ruiz C; Schmid-Burgk JL; Häussinger D; Winter GE; Fischer ES; Słabicki M; Gillingham D; Ebert BL; Thomä NH
    Nat Chem Biol; 2024 Jan; 20(1):93-102. PubMed ID: 37679459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted protein degradation via intramolecular bivalent glues.
    Hsia O; Hinterndorfer M; Cowan AD; Iso K; Ishida T; Sundaramoorthy R; Nakasone MA; Imrichova H; Schätz C; Rukavina A; Husnjak K; Wegner M; Correa-Sáez A; Craigon C; Casement R; Maniaci C; Testa A; Kaulich M; Dikic I; Winter GE; Ciulli A
    Nature; 2024 Mar; 627(8002):204-211. PubMed ID: 38383787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of cellular degradation kinetics for understanding mechanisms in targeted protein degradation.
    Riching KM; Caine EA; Urh M; Daniels DL
    Chem Soc Rev; 2022 Jul; 51(14):6210-6221. PubMed ID: 35792307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.